https://www.nasdaq.com/press-release/aditxt-signs-amendment-to-extend-worldwide-licensing-agreement-granting-exclusivity
https://www.nasdaq.com/press-release/aditxt-signs-share-exchange-agreement-to-acquire-aipharma-2021-12-28
https://www.nasdaq.com/press-release/aditxt-inc.-signs-non-binding-letter-of-intent-to-acquire-point-of-care-diagnostic
https://www.nasdaq.com/press-release/aditxt-announces-closing-of-%2417.4-million-firm-commitment-public-offering-of-common
https://www.nasdaq.com/press-release/aditxt-extends-the-timeline-to-sign-the-definitive-agreement-to-acquire-aipharma
https://www.nasdaq.com/press-release/aditxt-announces-pricing-of-%2417.4-million-firm-commitment-public-offering-of-common
https://www.nasdaq.com/press-release/aditxt-announces-proposed-public-offering-of-common-stock-and-warrants-2021-11-30
https://www.nasdaq.com/press-release/the-largest-law-enforcement-agency-in-the-state-of-kansas-johnson-county-sherriffs
https://www.nasdaq.com/press-release/aditxt-webinar-at-2pm-et-to-explore-preseco-results-2021-11-12
https://www.nasdaq.com/press-release/aditxt-provides-an-update-regarding-its-target-acquisition-aipharma-global-holdings
https://www.nasdaq.com/press-release/aditxt-partners-with-clx-health-to-offer-aditxtscoretm-for-covid-19-immune-monitoring
https://www.nasdaq.com/press-release/aditxt-announces-closing-of-%244.25-million-public-offering-2021-10-20
https://www.nasdaq.com/press-release/aditxt-to-present-at-the-dawson-james-6th-annual-small-cap-growth-conference-in
https://www.nasdaq.com/press-release/aditxt-announces-pricing-of-%244.25-million-public-offering-2021-10-18
https://www.nasdaq.com/press-release/aditxt-to-present-at-the-ld-micro-main-event-in-los-angeles-on-october-13-2021-2021
https://www.nasdaq.com/press-release/aipharma-signs-binding-agreement-to-sell-to-aditxt-inc-nasdaq%3a-adtx.-aipharma-is-the
https://www.nasdaq.com/press-release/aditxt-signs-a-transaction-agreement-to-acquire-aipharma-rights-holder-of-antiviral
https://www.nasdaq.com/press-release/aditxt-appoints-corinne-pankovcin-as-president-and-thomas-j.-farley-as-chief
https://www.nasdaq.com/press-release/aditxt-inc.-and-spheredx-launch-aditxtscoretm-for-covid-19-in-kentucky-ohio-and
https://www.nasdaq.com/press-release/aditxt-announces-closing-of-%2411-million-registered-direct-offering-and-funding-of
https://www.nasdaq.com/press-release/aditxt-announces-pricing-of-%2411.0-million-registered-direct-offering-priced-at-the
https://www.nasdaq.com/press-release/aditxt-inc.-signs-letter-of-intent-for-exclusive-rights-to-negotiate-the-acquisition
https://www.nasdaq.com/press-release/aditxt-inc.-and-great-lakes-medical-laboratory-launch-aditxtscore-for-covid-19-in
https://www.nasdaq.com/press-release/aditxt-provides-update-on-aditxtreprogrammingstm-apoptotic-dna-immunotherapy
https://www.nasdaq.com/press-release/aditxt-launches-high-sensitivity-neutralizing-antibody-test-to-detect-individual
https://www.nasdaq.com/press-release/aditxt-opens-its-first-high-capacity-immune-monitoring-center-in-richmond-va-2021-07
https://www.nasdaq.com/press-release/aditxt-announces-the-appointment-of-dr.-lauren-chung-to-its-board-of-directors-2021
https://www.nasdaq.com/press-release/aditxt-set-to-join-russell-microcapr-index-2021-06-15
https://www.nasdaq.com/press-release/aditxt-signs-channel-partner-agreement-with-meridian-hsn-to-make-aditxtscoretm-for
https://www.nasdaq.com/press-release/aditxt-to-establish-state-of-the-art-immune-monitoring-center-in-richmond-va-2021-05
https://www.nasdaq.com/press-release/aditxt-therapeutics-names-sunny-uberoi-as-its-first-chief-communications-officer-2021
https://www.nasdaq.com/press-release/healthbar-becomes-aditxtscoretm-channel-partner-to-offer-aditxtscoretm-for-covid-19
https://www.nasdaq.com/press-release/collection-sites-llc-named-aditxtscoretm-channel-partner-to-offer-aditxtscoretm-for-0
https://www.nasdaq.com/press-release/collection-sites-llc-named-aditxtscoretm-channel-partner-to-offer-aditxtscoretm-for
https://www.nasdaq.com/press-release/aditxt-to-initiate-first-in-human-clinical-trials-with-its-therapeutics-programs-in
https://www.nasdaq.com/press-release/aditxt-announces-participation-in-the-benzinga-biotech-small-cap-conference-2021-03
https://www.nasdaq.com/press-release/eazy-testing-inc.-becomes-aditxtscoretm-channel-partner-to-offer-aditxtscoretm-for
https://www.nasdaq.com/press-release/immunologist-and-clinical-transplant-expert-dolly-b.-tyan-phd-joins-aditxt-as-senior
https://www.nasdaq.com/press-release/aditxt-secures-%245-million-financing-to-scale-aditxtscoretm-operational-capacity-2021
https://www.nasdaq.com/press-release/aditxtscoretm-immune-monitoring-service-will-be-operational-on-february-1st-2021-01
https://www.nasdaq.com/press-release/aditxt-signs-distribution-agreement-with-todos-medical-ltd.-for-aditxtscoretm-for
https://www.nasdaq.com/press-release/aditxt-to-present-at-the-13th-annual-ld-micro-main-event-conference-2020-12-08
https://www.nasdaq.com/press-release/physician-and-media-personality-dr.-drew-and-aditxt-ceo-to-reveal-and-discuss-their
https://www.nasdaq.com/press-release/aditxt-appoints-anthony-voorhies-as-head-of-business-development-for-aditxtscoretm
https://www.nasdaq.com/press-release/aditxt-secures-clia-certification-for-aditxtscoretm-laboratory-operations-in-richmond
https://www.nasdaq.com/press-release/aditxt-provides-business-update-and-files-third-quarter-2020-10-q-2020-11-13
https://www.nasdaq.com/press-release/aditxt-announces-first-aditxtengagetm-event-continuing-series-of-investor
https://www.nasdaq.com/press-release/former-chief-medical-officer-and-assistant-secretary-for-health-affairs-of-the-u.s.
https://www.nasdaq.com/press-release/aditx-therapeutics-to-present-at-h.c.-wainwright-22nd-annual-global-investment
https://www.nasdaq.com/press-release/aditx-therapeutics-announces-closing-of-upsized-%249.6-million-follow-on-public
https://www.nasdaq.com/press-release/physician-and-media-personality-dr.-drew-pinsky-dr.-drew-joins-aditx-therapeutics-as
https://www.nasdaq.com/press-release/aditxt-signs-collaboration-agreement-with-salveo-diagnostics-to-commercialize
https://www.nasdaq.com/press-release/aditx-therapeutics-announces-pricing-of-%249.6-million-follow-on-public-offering-2020
https://www.nasdaq.com/press-release/ld-micro-360-companies-set-to-present-this-week-2020-08-31
https://www.nasdaq.com/press-release/aditx-therapeutics-to-present-at-the-ld-500-virtual-conference-2020-08-27
https://www.nasdaq.com/press-release/head-of-rd-for-the-new-analyte-ventures-at-abbott-diabetes-care-namvar-kiaie-joins
https://www.nasdaq.com/press-release/aditxt-submits-emergency-use-authorization-eua-application-for-aditxtscoretm-for
https://www.nasdaq.com/press-release/former-president-of-the-global-business-unit-at-schering-ag-dr.-joachim-friedrich
https://www.nasdaq.com/press-release/aditxt-introduces-aditxtscoretm-for-covid-19-and-announces-the-completion-of
https://www.nasdaq.com/press-release/aditx-therapeutics-appoints-jeff-ramson-wall-street-veteran-and-founder-of-pcg
https://www.nasdaq.com/press-release/founding-partner-of-securities-law-firm-anthony-l.g.-laura-anthony-appointed-to-aditx
https://www.nasdaq.com/press-release/aditxt-to-present-at-zooming-with-ld-2020-07-22
https://www.nasdaq.com/press-release/former-cfo-of-blackrock-capital-investment-corporation-and-aig-capital-partners
https://www.nasdaq.com/press-release/zooming-with-ld-to-feature-10-distinct-companies-july-20th-31st-2020-07-16
